InVivo Biosystems Blog

Home > InVivo Biosystems Blog

Using Zebrafish to Combat Cognitive Decline: How a Biopharmaceutical Company Leveraged a Zebrafish Model to characterize a Compound for Neurodegenerative Disease Therapeutics

By:

June 28, 2023

The zebrafish has become an increasingly prevalent model: but in this series we are going to dive deeper, discussing their unique benefits.

23 June

Revolutionizing Rare Disease Research: Unleashing the Power of RareResolve for Rapid Discovery in Rare Disease Medicine

By:

Chris Hopkins ,

Alexandra Narin ,

June 23, 2023

As personalized medicine and the discovery of de novo variants that cause disease continue to grow, researchers are increasingly in need of alternative models

12 June

Whitepaper: What is IND?

By:

Alexandra Narin ,

June 12, 2023

As personalized medicine and the discovery of de novo variants that cause disease continue to grow, researchers are increasingly in need of alternative models

5 June

Fast, Cost Effective Compound Efficacy Testing using Zebrafish

By:

Alexandra Narin ,

June 5, 2023

As personalized medicine and the discovery of de novo variants that cause disease continue to grow, researchers are increasingly in need of alternative models

11 May

Better Together? Zebrafish and Mice Models should be utilized in Conjunction.

By:

Alexandra Narin ,

May 11, 2023

As personalized medicine and the discovery of de novo variants that cause disease continue to grow, researchers are increasingly in need of alternative models

4 May

A humanized Caenorhabditis elegans model of Hereditary Spastic Paraplegia [Where are they now: Customer Story]

By:

Alexandra Narin ,

May 4, 2023

The zebrafish has become an increasingly prevalent model: but in this series we are going to dive deeper, discussing their unique benefits.

7 February

For Studying Host-Microbe Interactions, Why Choose Zebrafish?

By:

Alexandra Narin ,

Joseph Bruckner ,

February 7, 2023

Gut microbiota impacts nearly every aspect of health, but researching it can be tricky due to differences between humans and commonly

1 February

Leaky Gut Assays in Animal Models

By:

Alexandra Narin ,

Chris Hopkins ,

February 1, 2023

Inflammation in your intestine is detrimental to overall health, and can create many complications. So how is this phenomenon researched?

Connect with us

stay updated..

The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.

An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.

Quick Links

Headquarters: 1505 Westec Drive, Eugene, OR 97402

1.844.663.8749.

InVivo Biosystems Blog

Featured Posts

A Natural Fit – Using Zebrafish to Evaluate Natural Compounds for Anti-Inflammatory Properties

Using Zebrafish CRO to Accelerate Grant Application Process

Revolutionizing Rare Disease Research: Unleashing the Power of RareResolve for Rapid Discovery in Rare Disease Medicine

Recent Posts

Using Zebrafish to Combat Cognitive Decline: How a Biopharmaceutical Company Leveraged a Zebrafish Model to characterize a Compound for Neurodegenerative Disease Therapeutics

Revolutionizing Rare Disease Research: Unleashing the Power of RareResolve for Rapid Discovery in Rare Disease Medicine

Whitepaper: What is IND?

Fast, Cost Effective Compound Efficacy Testing using Zebrafish

Better Together? Zebrafish and Mice Models should be utilized in Conjunction.

A humanized Caenorhabditis elegans model of Hereditary Spastic Paraplegia [Where are they now: Customer Story]

For Studying Host-Microbe Interactions, Why Choose Zebrafish?

Leaky Gut Assays in Animal Models

Connect with us